PRKAR2A Antikörper
-
- Target Alle PRKAR2A Antikörper anzeigen
- PRKAR2A (Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha (PRKAR2A))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser PRKAR2A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS)
- Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
- Immunogen
- Full length human recombinant protein of human PRKAR2A (NP_004148) produced in HEK293T cell.
- Klon
- 1A7
- Isotyp
- IgG1
- Top Product
- Discover our top product PRKAR2A Primärantikörper
-
anti-Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha (PRKAR2A) (AA 1-105) antibody
PRKAR2A Reaktivität: Human WB, ELISA, IF, IHC (p) Wirt: Maus Monoclonal 6A9 unconjugated
anti-Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha (PRKAR2A) (AA 43-205), (Regulatory Subunit) antibodyPRKAR2A Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha (PRKAR2A) (AA 1-404) antibodyPRKAR2A Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha (PRKAR2A) (N-Term) antibodyPRKAR2A Reaktivität: Human, Ratte, Maus WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha (PRKAR2A) (AA 1-382) antibodyPRKAR2A Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha (PRKAR2A) (Center) antibodyPRKAR2A Reaktivität: Human WB, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha (PRKAR2A) (pSer99) antibodyPRKAR2A Reaktivität: Human WB Wirt: Kaninchen Monoclonal unconjugated
anti-Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha (PRKAR2A) antibodyPRKAR2A Reaktivität: Human, Ratte, Affe, Hund WB, IHC, IF, FACS Wirt: Maus Monoclonal 5F1 unconjugated
anti-Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha (PRKAR2A) antibodyPRKAR2A Reaktivität: Human WB, ICC Wirt: Maus Monoclonal Hs-36 unconjugated
anti-Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha (PRKAR2A) (pSer96) antibodyPRKAR2A Reaktivität: Human WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB 1:2000, IHC 1:50, IF 1:100, Flow 1:100
- Kommentare
-
The concentration of the product may vary between diferrent lots.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5-1.0 mg/mL
- Buffer
- PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
- Target
- PRKAR2A (Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha (PRKAR2A))
- Andere Bezeichnung
- PRKAR2A (PRKAR2A Produkte)
- Synonyme
- PKR2 antikoerper, PRKAR2 antikoerper, prkar2a antikoerper, zgc:85886 antikoerper, PRKAR2A antikoerper, 1110061A24Rik antikoerper, AI317181 antikoerper, AI836829 antikoerper, RII(alpha) antikoerper, protein kinase cAMP-dependent type II regulatory subunit alpha antikoerper, protein kinase, cAMP-dependent, regulatory, type II, alpha, B antikoerper, protein kinase, cAMP-dependent, regulatory, type II, alpha antikoerper, protein kinase, cAMP dependent regulatory, type II alpha antikoerper, protein kinase cAMP-dependent type 2 regulatory subunit alpha antikoerper, PRKAR2A antikoerper, prkar2ab antikoerper, Prkar2a antikoerper
- Molekulargewicht
- 45.3kDa
- Gen-ID
- 5576
- NCBI Accession
- NM_004157
- HGNC
- 5576
- Pathways
- Hedgehog Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
-
